Why did operating margins decline despite higher gross margins?

The filing says the year-over-year decline in both Operating income margin (16.8% vs 18.1%) and Adjusted operating income margin (22.1% vs 23.3%) reflects increased brand investment, which more than offset the benefit from gross profit margin expansion and savings from Our Vue Forward.

What drove the increase in the effective tax rate?

The filing attributes the rise in the effective tax rate to 33.6% from 25.1% and the Adjusted effective tax rate to 28.9% from 25.3% to changes in the jurisdictional mix of income and reduced benefits derived from the Separation from the former parent company.

Where did sales change by segment during the quarter?

Self Care net sales rose to $1,625 million from $1,613 million, Essential Health rose to $1,202 million from $1,183 million, and Skin Health and Beauty declined to $1,072 million from $1,119 million. Volume declines were driven primarily by Skin Health and Beauty and Self Care.

What were the key nine-month non-operating and cash items?

For the nine months ended September 29, 2024, the company reported impairment charges of $578 million, restructuring expenses of $120 million, and interest expense, net of $283 million. Net cash flows from operating activities were $1.0 billion and free cash flow was $0.7 billion. Cash and cash equivalents were $1.1 billion and total debt was $8.7 billion.

KVUE 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed November 7, 2024. Cited figures are marked; the original filing is the authoritative source.

Kenvue Inc. reported third-quarter 2024 results for the fiscal period ended September 29, 2024, as described in a press release furnished as Exhibit 99.1.

Net sales decreased 0.4% to $3.9 billion^a ($3,899 million), reflecting Organic growth of 0.9% offset by a foreign currency headwind of 1.3%. Volume declined 1.6%, while value realization (price and mix) contributed 2.5%. Diluted EPS was $0.20 versus $0.23 a year earlier, and Adjusted diluted EPS was $0.28 versus $0.31.

Operating income margin fell to 16.8%^b from 18.1%, and Adjusted operating income margin fell to 22.1% from 23.3%, which the company attributed mainly to higher brand investment that more than offset gross margin expansion and savings from Our Vue Forward. The effective tax rate rose to 33.6% from 25.1%. For full-year 2024, the company expects Net sales growth and Organic growth toward the low end of its 1.0%-3.0% and 2.0%-4.0% outlook ranges, assuming an approximately 1% currency headwind.

It reaffirmed its Adjusted diluted EPS outlook of $1.10^c-$1.20. Nine-month results show net income of $737 million, impairment charges of $578 million, restructuring expenses of $120 million, and free cash flow of $0.7 billion, compared with $2.0 billion a year earlier. Net debt was $7.6 billion at September 29, 2024, up from $6.9 billion at December 31, 2023.

02—Key points

Key Highlights

Net sales fell 0.4% to $3,899 million; Organic growth was 0.9%, with a 1.3% foreign currency headwind.
Gross profit margin rose 100 basis points to 58.5%, and Adjusted gross profit margin rose 130 basis points to 60.7%, driven by supply chain productivity and value realization.
Diluted EPS was $0.20 versus $0.23 a year earlier; Adjusted diluted EPS was $0.28 versus $0.31.
Adjusted operating income margin declined to 22.1% from 23.3% due to higher brand investment.
The effective tax rate increased to 33.6% from 25.1%, reflecting jurisdictional mix changes and reduced benefits from the Separation.
Full-year 2024 Adjusted diluted EPS outlook of $1.10-$1.20 was reaffirmed, with Net sales and Organic growth expected toward the low end of their ranges.
Nine-month free cash flow was $0.7 billion versus $2.0 billion a year earlier, and net debt rose to $7.6 billion from $6.9 billion at year-end 2023.

03—Questions

Frequently Asked Questions

Why did operating margins decline despite higher gross margins?
The filing says the year-over-year decline in both Operating income margin (16.8% vs 18.1%) and Adjusted operating income margin (22.1% vs 23.3%) reflects increased brand investment, which more than offset the benefit from gross profit margin expansion and savings from Our Vue Forward.
What is the company's full-year 2024 outlook?
Assuming an approximately 1% currency headwind, Kenvue expects Net sales growth and Organic growth toward the low end of its 1.0%-3.0% and 2.0%-4.0% outlook ranges, respectively. It reaffirmed Adjusted diluted EPS guidance of $1.10-$1.20.
What drove the increase in the effective tax rate?
The filing attributes the rise in the effective tax rate to 33.6% from 25.1% and the Adjusted effective tax rate to 28.9% from 25.3% to changes in the jurisdictional mix of income and reduced benefits derived from the Separation from the former parent company.
Where did sales change by segment during the quarter?
Self Care net sales rose to $1,625 million from $1,613 million, Essential Health rose to $1,202 million from $1,183 million, and Skin Health and Beauty declined to $1,072 million from $1,119 million. Volume declines were driven primarily by Skin Health and Beauty and Self Care.
What were the key nine-month non-operating and cash items?
For the nine months ended September 29, 2024, the company reported impairment charges of $578 million, restructuring expenses of $120 million, and interest expense, net of $283 million. Net cash flows from operating activities were $1.0 billion and free cash flow was $0.7 billion. Cash and cash equivalents were $1.1 billion and total debt was $8.7 billion.

04—Continue

← View all 8-K filings